NCT01448174 Salusin-alpha - a New Factor in the Pathogenesis of Lipid Abnormalities in Hemodialysis Patients Status COMPLETED Phase PHASE4
NCT01442428 Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial Status WITHDRAWN Phase PHASE2/PHASE3
NCT01431105 Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities Status COMPLETED Phase PHASE1/PHASE2
NCT01386853 Efficacy and Safety Study of Pitavastatin and Atorvastatin in High Risk Hypercholesterolemic Patients Status UNKNOWN Phase PHASE3
NCT01372839 Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome Status UNKNOWN Phase PHASE4
NCT01370603 A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1) Status COMPLETED Phase PHASE3
NCT01370590 A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1) Status COMPLETED Phase PHASE3
NCT01363999 A Formulation Screening Study of Dalcetrapib and Atorvastatin in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01351025 Atorvastatin on Biomarkers of Inflammation, Coagulopathy, Angiogenesis & T-cells Status COMPLETED Phase PHASE2
NCT01334671 The Clinical Effect of Intensive Statin Therapy in STEMI Patients Before Emergency PCI Status UNKNOWN Phase PHASE3
NCT01332747 Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation Status COMPLETED Phase PHASE2
NCT01322711 Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes Status UNKNOWN Phase PHASE4
NCT01299597 A Single-centre Open Label Study to Investigate the Effect of Repeat Doses of SB-649868 on the Pharmacokinetics of Simvastatin and Atorvastatin in Healthy Male Volunteers. Status COMPLETED Phase PHASE1
NCT01299194 Atorvastatin in Bronchiectasis in Patients With Pseudomonas Aeruginosa Status COMPLETED Phase PHASE4
NCT01299181 A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis Status COMPLETED Phase PHASE4
NCT01293097 Intensive Statin Treatment in Chinese Coronary Artery Disease Patients Undergoing PCI Status COMPLETED Phase PHASE4
NCT01288469 Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) When Co-administered With High Dose of Atorvastatin in Patients With Primary Hypercholesterolemia Status COMPLETED Phase PHASE2
NCT01288443 Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy Status COMPLETED Phase PHASE2
NCT01279590 Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM) Status COMPLETED Phase PHASE2